These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 681490)

  • 1. Combined high-pressure liquid chromatography and radioimmunoassay method for the quantitation of delta 9-tetrahydrocannabinol and some of its metabolites in human plasma.
    Williams PL; Moffat AC; King LJ
    J Chromatogr; 1978 Aug; 155(2):273-83. PubMed ID: 681490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9- tetrahydrocannabinol and its metabolites in plasma and urine.
    Moffat AC; Williams PL; King LJ
    NIDA Res Monogr; 1982; 42():56-68. PubMed ID: 6294526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9-tetrahydrocannabinol metabolites in human urine.
    Williams PL; Moffat AC; King LJ
    J Chromatogr; 1979 Dec; 186():595-603. PubMed ID: 232708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The separation, identification, and quantitation of cannabinoids and their tau=butyldimethylsilyl, trimethylsilylacetate, and diethylphosphate derivatives using high-pressure liquid chromatography, gas-liquid chromatography, and mass spectrometry.
    Knaus EE; Coutts RT; Kazakoff CW
    J Chromatogr Sci; 1976 Nov; 14(11):525-30. PubMed ID: 977713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and analysis of delta 9-tetrahydrocannabinol in biological fluids by high-pressure liquid chromatography and GLC.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Jan; 66(1):20-6. PubMed ID: 833737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of delta 1-tetrahydrocannabinol in tissues and body fluids.
    Lindgren JE
    Arch Toxicol Suppl; 1983; 6():74-80. PubMed ID: 6312925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. delta 9-Tetrahydrocannabinol by GLC-MS validated radioimmunoassays of hemolyzed blood or serum.
    Yeager EP; Goebelsmann U; Soares JR; Grant JD; Gross SJ
    J Anal Toxicol; 1981; 5(2):81-4. PubMed ID: 6264224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 3H- and 125I-radioimmunoassay and gas chromatography/mass spectrometry for the determination of delta 9-tetrahydrocannabinol and cannabinoids in blood and serum.
    Hanson VW; Buonarati MH; Baselt RC; Wade NA; Yep C; Biasotti AA; Reeve VC; Wong AS; Orbanowsky MW
    J Anal Toxicol; 1983; 7(2):96-102. PubMed ID: 6304423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. IV. A comparison of five methods.
    Jones AB; ElSohly HN; Arafat ES; ElSohly MA
    J Anal Toxicol; 1984; 8(6):249-51. PubMed ID: 6097765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of cannabis use by the analysis of delta 9-tetrahydrocannabinol metabolites in blood and urine by combined HPLC and RIA.
    Law B; Mason PA; Moffat AC; King LJ
    J Anal Toxicol; 1984; 8(1):19-22. PubMed ID: 6323852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
    Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
    Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simple and sensitive HPLC-UV method for the simultaneous determination of cannabidiol and Δ(9)-tetrahydrocannabinol in rat plasma.
    Zgair A; Wong JC; Sabri A; Fischer PM; Barrett DA; Constantinescu CS; Gershkovich P
    J Pharm Biomed Anal; 2015 Oct; 114():145-51. PubMed ID: 26048666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of delta 1-tetrahydrocannabinol in plasma to the low picogram range by gas chromatography-mass spectrometry using metastable ion detection.
    Harvey DJ; Leuschner JT; Paton WD
    J Chromatogr; 1980 Dec; 202(1):83-92. PubMed ID: 6260826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 125I radioimmunoassay of delta-9-tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method.
    Owens SM; McBay AJ; Reisner HM; Perez-Reyes M
    Clin Chem; 1981 Apr; 27(4):619-24. PubMed ID: 6258825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of liquid chromatography with ultraviolet detection and gas chromatography with electron-capture detection for the determination of delta 9-tetrahydrocannabinol-11-oic acid in urine.
    Karlsson L; Roos C
    J Chromatogr; 1984 Mar; 306():183-9. PubMed ID: 6325483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry.
    König S; Aebi B; Lanz S; Gasser M; Weinmann W
    Anal Bioanal Chem; 2011 Apr; 400(1):9-16. PubMed ID: 21311875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.